Surviving Sepsis Campaign COVID-19 Guidelines Therapeutics Update

The Surviving Sepsis Campaign (SSC) has updated the previously released Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19). 

In the newly released first evidence-based update of the SSC COVID-19 guidelines, the panel issued nine statements related to ICU patients with severe or critical COVID-19. Our expert panel covered the methods and review of the first edition of the guidelines and discussed supportive care, antiviral therapy and future directions.

You can replay our latest COVID-19 webinar and learn more about the rapid clinical guidelines methodology and its application to public health emergencies here.

The experts

Co-Presenters:

Prof Flavia MACHADO – Head of the Intensive Care Section of the Anaesthesiology, Pain and Intensive Care Department and Professor of Intensive Care at the Federal University of São Paulo (BR). Current board member of the Surviving Sepsis Campaign International Guidelines and the International Sepsis Forum (ISF) Council.

Dr Marlies OSTERMANN –  Consultant in Critical Care and Nephrology at Guy’s & St Thomas’ Hospital, London (UK). Current Chair of the ESICM AKI Section and Course Director of the Society’s RRT State of the Art Master Class.

Dr Laura EVANS – Director of Critical Care at University of Washington Medical Center, Seattle (US). Current SCCM Adult Guidelines Co-Chair, Consultant and member of the Society of Critical Care Medicine’s Council.

Moderators:

Prof Maurizio CECCONI – Head of the Anaesthesia and Intensive Care Department at the Humanitas Research Hospital, Milan (IT) and Professor of Anaesthesia and Intensive Care at the Humanitas University, Milan (IT). Current ESICM President.

Dr Laura GALARZA – Consultant in Intensive Care at Hospital General Universitario, Castellón (ES). Current Deputy Chair of ESICM NEXT Committee.

This webinar is part of the 

>> Other resources available here <<